Increased incidence of delayed methotrexate elimination in pediatric patients with Philadelphia-chromosome positive (Ph+) or ABL-class fusion positive (ABL-Class) acute lymphoblastic leukemia treated with imatinib: Results of a retrospective cohort study by the italian association of pediatric hematology-oncology (AIEOP)
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Nicolò Peccatori, Sofia Arnaboldi, Veronica Leoni, Stefania Gaspari, Rosanna Parasole, Nicola Santoro, Claudia Pellegrinelli, Nicoletta Bertorello, Raffaele Mattera, Elena Chiocca, Delia Russo, Richard Fabian Schumacher, Daniela Guardo, Anita Spirito, Rossella Mura, Sara Lovaste, Stefania Monterisi, Calogero Mazzara, Grazia Fazio, Maria Valsecchi, Paola De Lorenzo, Alessandra Sala, Antonella Colombini, Marco Spinelli, Giacomo Gotti, Laura Bettini, Andrea Biondi, Valentino Conter, Adriana Balduzzi, Carmelo Rizzari
Institutions: University of Milano-Bicocca, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Ospedale Pediatrico Giovanni XXIII, Ospedale Papa Giovanni XXIII, Ospedale Regina Margherita, University of Padua, Meyer Children's Hospital, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Istituto Giannina Gaslini, Casa Sollievo della Sofferenza, Azienda Ospedaliera G. Brotzu, Centre Hospitalier Universitaire Vaudois, University of Lausanne
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108450864
Cites:
Cited by:
Related to: